Prof Andrea Rita Horvath, MD, PhD, FRCPath(UK), FRCPA
Prof Horvath is Director of Chemical Pathology in New South Wales Health Pathology at Prince of Wales Hospital in Sydney. She is conjoint professor at the University of New South Wales, honorary professor at the University of Sydney and at Macquarie University. She had multiple national and international leadership roles: President of the Hungarian Society of Laboratory Medicine, President of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM); and Member of the Board of Directors of the American Association of Clinical Chemistry, currently named the Association of Diagnostic Laboratory Medicine (AACC/ADLM). She held the 20th and 10th position on The Pathologist’s Power List of the 100 Most Influential Pathology Professionals in 2015 and 2018, respectively. She was also one of the three senior editors of the 6th edition of the Tietz Textbook and the 8th edition of the Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics.
For 6 years she chaired the EBLM Committee of the International Federation of Clinical Chemistry and Laboratory Medicine and for 8 years she was vice chair of the EBLM Committee of AACC/ADLM. She was the founder and past chair of the Test Evaluation Working Group of EFLM. Currently she chairs an EFLM Task Force Group on Outcome-Based Analytical Performance Specifications for Tests, the AACB working party on harmonization of critical risk results and the AACB-RCPA working group on the preanalytical aspects of glucose testing. She is also member of AACB’s Executive Committee on Harmonisation.
Her key research interest and passion are evidence-based laboratory medicine (EBLM), evidence-based evaluation of biomarkers and effectiveness and safety of laboratory testing.